Cargando…
FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study
The relationship between clinical research and the pharmaceutical industry has placed clinical trials in jeopardy. According to the medical literature, more than 70% of clinical trials are industry-funded. Many of these trials remain unpublished or have methodological flaws that distort their result...
Autores principales: | Marin dos Santos, Douglas H., Atallah, Álvaro N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485238/ https://www.ncbi.nlm.nih.gov/pubmed/26131374 http://dx.doi.org/10.7717/peerj.1015 |
Ejemplares similares
-
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
por: Miller, Jennifer E, et al.
Publicado: (2015) -
Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
por: Talebi, Ramtin, et al.
Publicado: (2020) -
Psychological Autopsy Studies as Diagnostic Tools: Are they Methodologically Flawed?
por: Hjelmeland, Heidi, et al.
Publicado: (2012) -
Increasing retractions of meta-analyses publications for methodological flaw
por: Chen, Chia-Yun, et al.
Publicado: (2021) -
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology
por: Garnett, Sally Anne, et al.
Publicado: (2013)